SCHEMBL25307756

SCHEMBL25307756

O=C(O)NCc1ncc(-c2ccc(C(F)(F)F)cc2)[nH]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN2A Q99250 2/20 0.50
TRPV1 Q8NER1 1/20 0.46
SSTR3 P32745 1/20 0.43
NPY5R Q15761 1/20 0.43
SCN10A Q9Y5Y9 1/20 0.43
TP53 P04637 1/20 0.43
MAPT P10636 1/20 0.43
NTRK1 P04629 1/20 0.41
ROCK2 O75116 2/20 0.41
PRKCA P17252 1/20 0.41
GRK2 P25098 1/20 0.41
CCNB2 O95067 1/20 0.41
CDK1 P06493 1/20 0.41
CCNB1 P14635 1/20 0.41
GSK3A P49840 1/20 0.41
GSK3B P49841 1/20 0.41
CCNB3 Q8WWL7 1/20 0.41
ULK1 O75385 1/20 0.40
COMT P21964 1/20 0.40
KLK1 P06870 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25304321 0.85 PTGES (0.42) SCN10A
SCHEMBL25307004 0.84 SCN10A (0.63) SCN2ANPY5RSCN10A
SCHEMBL30590468 0.83 CACNA1H (0.51) SCN2ATRPV1SSTR3NPY5RSCN10A
SCHEMBL16210371 0.82 MGLL (0.50) SCN2AROCK2PRKCAGRK2KLK1
SCHEMBL25305748 0.79 SCN2A (0.50) SCN2ASSTR3SCN10A
SCHEMBL25259225 0.78 PDE2A (0.44) SCN2ACOMT
SCHEMBL5758675 0.77 SCN2A (0.54) SCN2ATRPV1SSTR3NPY5RSCN10A
SCHEMBL25833757 0.76 SCN2A (0.55) SCN2ATRPV1SSTR3NPY5RSCN10A
SCHEMBL25303515 0.76 SCN2A (0.55) SCN2ATRPV1SSTR3NPY5RSCN10A
SCHEMBL5758137 0.75 SCN2A (0.62) SCN2ATRPV1SSTR3NPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023135057-A1 BICYCLIC TRIAZINE DERIVATIVES FOR THE TREATMENT OF CANCER DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2023-07-20 WO disclosed